The Role of Genetic Polymorphisms as Related to One-Carbon Metabolism, Vitamin B6, and Gene-Nutrient Interactions in Maintaining Genomic Stability and Cell Viability in Chinese Breast Cancer Patients

• Published in: International journal of molecular sciences Vol. 17; no. 7; p. 1003
• Main Authors: Wu, Xiayu, Xu, Weijiang, Zhou, Tao, Cao, Neng, Ni, Juan, Zou, Tianning, Liang, Ziqing, Wang, Xu, Fenech, Michael
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-07-2016; MDPI
• Subjects: Adult; Breast cancer; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Carbon; Case-Control Studies; Cell Line, Tumor; Cell Survival; Cells; Female; Ferredoxin-NADP Reductase - genetics; Ferredoxin-NADP Reductase - metabolism; FMOCM; gene-nutrient interaction; Genes; genetic polymorphisms; Genetics; Genomic Instability; Genomics; Glycine Hydroxymethyltransferase - genetics; Glycine Hydroxymethyltransferase - metabolism; GSACV; Humans; Metabolism; Nutrients; Polymorphism; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Vitamin B 6 - metabolism; vitamin B6; vitamin B6; breast cancer; gene-nutrient interaction; FMOCM; genetic polymorphisms; GSACV
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms17071003

Folate-mediated one-carbon metabolism (FMOCM) is linked to DNA synthesis, methylation, and cell proliferation. Vitamin B6 (B6) is a cofactor, and genetic polymorphisms of related key enzymes, such as serine hydroxymethyltransferase (SHMT), methionine synthase reductase (MTRR), and methionine synthase (MS), in FMOCM may govern the bioavailability of metabolites and play important roles in the maintenance of genomic stability and cell viability (GSACV). To evaluate the influences of B6, genetic polymorphisms of these enzymes, and gene-nutrient interactions on GSACV, we utilized the cytokinesis-block micronucleus assay (CBMN) and PCR-restriction fragment length polymorphism (PCR-RFLP) techniques in the lymphocytes from female breast cancer cases and controls. GSACV showed a significantly positive correlation with B6 concentration, and 48 nmol/L of B6 was the most suitable concentration for maintaining GSACV in vitro. The GSACV indexes showed significantly different sensitivity to B6 deficiency between cases and controls; the B6 effect on the GSACV variance contribution of each index was significantly higher than that of genetic polymorphisms and the sample state (tumor state). SHMT C1420T mutations may reduce breast cancer susceptibility, whereas MTRR A66G and MS A2756G mutations may increase breast cancer susceptibility. The role of SHMT, MS, and MTRR genotype polymorphisms in GSACV is reduced compared with that of B6. The results appear to suggest that the long-term lack of B6 under these conditions may increase genetic damage and cell injury and that individuals with various genotypes have different sensitivities to B6 deficiency. FMOCM metabolic enzyme gene polymorphism may be related to breast cancer susceptibility to a certain extent due to the effect of other factors such as stress, hormones, cancer therapies, psychological conditions, and diet. Adequate B6 intake may be good for maintaining genome health and preventing breast cancer.